MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Novel Multiple System Atrophy Subtypes Identified Using Unsupervised Machine Learning Algorithms

H. Sekiya, D. Ono, A. Maier, D. Dickson (Jacksonville, USA)

Meeting: 2025 International Congress

Keywords: Multiple system atrophy(MSA): Anatomy, Multiple system atrophy(MSA): Clinical features, Multiple system atrophy(MSA): Pathophysiology

Category: MSA, PSP, CBS: Pathophysiology / Molecular Mechanisms of Disease

Objective: To identify a novel disease subtype of multiple system atrophy (MSA) by applying machine learning algorithms to a large cohort of autopsy-confirmed MSA.

Background: MSA shows various degrees of degeneration in striatonigral and olivopontocerebellar systems; however, its progression remains to be elucidated. Recently, probabilistic disease progression models have been developed, yet this approach has not been applied to MSA.

Method: We analyzed 167 autopsy-confirmed MSA patients. Neuronal loss in five regions (putamen, substantia nigra, pontine nucleus, inferior olivary nucleus, and cerebellar Purkinje cells) was semi-quantitatively assessed using a 4-point scale for input into an unsupervised learning algorithm (Subtype and Stage Inference – SuStaIn). Clinical information was collected from medical records. The immunoreactive area of α-synuclein immunohistochemistry (IHC) was quantitatively measured using a color deconvolution algorithm in the putamen, substantia nigra, pontine nucleus, inferior olivary nucleus, and cerebellar dentate nucleus. We examined correlations between SuStaIn subtyping results and both clinical information and pathological findings.

Results: The SuStaIn algorithm classified patients into three subtypes: subtype 1 (S1, n=86), subtype 2 (S2, n=44), and subtype 3 (S3, n=30). S1 showed initial neuronal loss in the striatonigral system, S2 in the olivopontocerebellar system, while S3 exhibited early neuronal loss in both systems. These patterns were validated by stained area analysis with S3 showing greater areas in the putamen compared to S2 (P = 0.02) and in the pontine and dentate nuclei compared to S1 (P = 0.001 and P = 0.016). Parkinsonism was predominant in 97% of S1 and 63% of S3, while cerebellar symptoms were predominant in 66% of S2 (P < 0.0001). S3 demonstrated shorter disease duration (6±2 years) compared to S1 and S2 (both 8±3 years; P < 0.05), more frequent rapid progression and early falls, and less frequent cognitive impairment. A positive correlation was observed between the SuStaIn stage and disease duration (r = 0.25, P = 0.0014).

Conclusion: This study identified a unique MSA subtype characterized by early involvement of both striatonigral and olivopontocerebellar pathology and poor prognosis. The SuStaIn algorithm shows promise for novel classifications of MSA subtypes.

To cite this abstract in AMA style:

H. Sekiya, D. Ono, A. Maier, D. Dickson. Novel Multiple System Atrophy Subtypes Identified Using Unsupervised Machine Learning Algorithms [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/novel-multiple-system-atrophy-subtypes-identified-using-unsupervised-machine-learning-algorithms/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/novel-multiple-system-atrophy-subtypes-identified-using-unsupervised-machine-learning-algorithms/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley